These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 16201937
1. Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study. Fabian TC, File TM, Embil JM, Krige JE, Klein S, Rose A, Melnick D, Soto NE. Surg Infect (Larchmt); 2005; 6(3):269-82. PubMed ID: 16201937 [Abstract] [Full Text] [Related]
4. Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial. Nakane T, Tamura K, Hino M, Tamaki T, Yoshida I, Fukushima T, Tatsumi Y, Nakagawa Y, Hatanaka K, Takahashi T, Akiyama N, Tanimoto M, Ohyashiki K, Urabe A, Masaoka T, Kanamaru A, Japan Febrile Neutropenia Study Group. J Infect Chemother; 2015 Jan; 21(1):16-22. PubMed ID: 25239059 [Abstract] [Full Text] [Related]
5. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections. Nichols RL, Smith JW, Geckler RW, Wilson SE. South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590 [Abstract] [Full Text] [Related]
15. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections. Garau J, Blanquer J, Cobo L, Corcia S, Daguerre M, de Latorre FJ, León C, Del Nogal F, Net A, Rello J. Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899 [Abstract] [Full Text] [Related]
16. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial. Basoli A, Meli EZ, Mazzocchi P, Speranza V. Scand J Infect Dis; 1997 Nov; 29(5):503-8. PubMed ID: 9435041 [Abstract] [Full Text] [Related]
18. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group. Geroulanos SJ. J Antimicrob Chemother; 1995 Jul; 36 Suppl A():191-205. PubMed ID: 8543495 [Abstract] [Full Text] [Related]
19. Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin. Maggioni P, Di Stefano F, Facchini V, Irato S, Mancuso S, Colombo M, Massobrio M, Melis GB, Crosignani P. J Chemother; 1998 Apr; 10(2):114-21. PubMed ID: 9603636 [Abstract] [Full Text] [Related]
20. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. Chen Z, Wu J, Zhang Y, Wei J, Leng X, Bi J, Li R, Yan L, Quan Z, Chen X, Yu Y, Wu Z, Liu D, Ma X, Maroko R, Cooper A. BMC Infect Dis; 2010 Jul 21; 10():217. PubMed ID: 20663130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]